Contact

All Stories

  1. Cardiometabolic disease risk: the joint role of the UCP1, UCP2, UCP3, and FTO gene variants

    Article • Biochimie, September 2026, Elsevier

    DSc Lidia Karabon

  2. miR-155-5p Silencing Does Not Alter BTLA Molecule Expression in CLL T Cells: Implications for Targeted Immunotherapy

    Article • Biomolecules, October 2025, MDPI AG

    DSc Lidia Karabon

  3. Effect of HVEM/CD160 Variations on the Clear Cell Renal Carcinoma Risk and Overall Survival

    Article • International Journal of Molecular Sciences, June 2024, MDPI AG

    DSc Lidia Karabon

  4. Effect of HVEM/CD160 Variations on the Clear Cell Renal Carcinoma Risk and Overall Survival

    Article • May 2024, MDPI AG

    DSc Lidia Karabon

  5. BTLA biology in cancer: from bench discoveries to clinical potentials

    Article • Biomarker Research, January 2024, Springer Science + Business Media

    DSc Lidia Karabon

  6. NGS Sequencing Reveals New UCP1 Gene Variants Potentially Associated with MetS and/or T2DM Risk in the Polish Population—A Preliminary Study

    Article • Genes, March 2023, MDPI AG

    DSc Lidia Karabon

  7. The Variations’ in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis

    Article • International Journal of Molecular Sciences, January 2023, MDPI AG

    DSc Lidia Karabon

  8. BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production

    Article • Cells, November 2021, MDPI AG

    DSc Lidia Karabon

  9. Editorial: Genetic and Epigenetic Control of Immune Responses

    Article • Frontiers in Immunology, October 2021, Frontiers

    DSc Lidia Karabon

  10. Immune Checkpoint Molecules—Inherited Variations as Markers for Cancer Risk

    Article • Frontiers in Immunology, January 2021, Frontiers

    DSc Lidia Karabon

  11. SNP-SNP Interaction in Genes Encoding PD-1/PD-L1 Axis as a Potential Risk Factor for Clear Cell Renal Cell Carcinoma

    Article • Cancers, November 2020, MDPI AG

    DSc Lidia Karabon

  12. Association of Common Variants of TNFSF13 and TNFRSF13B Genes with CLL Risk and Clinical Picture, as Well as Expression of Their Products—APRIL and TACI Molecules

    Article • Cancers, October 2020, MDPI AG

    DSc Lidia Karabon

  13. Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients

    Article • Journal of Immunology Research, July 2020, Hindawi Publishing Corporation

    DSc Lidia Karabon

  14. Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy

    Article • Central European Journal of Immunology, January 2020, Termedia Sp. z.o.o.

    DSc Lidia Karabon

  15. sFasL-mediated induction of neutrophil activation in patients with type 2 diabetes mellitus

    Article • PLOS One, July 2018, PLOS

    DSc Lidia Karabon

  16. Polymorphisms in immune-inflammatory response genes and the risk of deficit schizophrenia

    Article • Schizophrenia Research, March 2018, Elsevier

    DSc Lidia Karabon

  17. Genetic Factors Influencing Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Journal of Immunology Research, January 2018, Hindawi Publishing Corporation

    Mirosław Markiewicz, Dr Edyta Agnieszka Pawlak-Adamska, DSc Lidia Karabon

  18. The mRNA expression levels of uncoupling proteins 1 and 2 in mononuclear cells from patients with metabolic disorders: obesity and type 2 diabetes mellitus

    Article • Postępy Higieny i Medycyny Doświadczalnej, October 2017, Index Copernicus

    DSc Lidia Karabon

  19. PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS

    Article • Journal of Neuroimmunology, April 2017, Elsevier

    DSc Lidia Karabon

  20. Erratum to: CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease

    Article • Endocrine, February 2017, Springer Science + Business Media

    DSc Lidia Karabon

  21. Role of UCP1 Gene Variants in Interethnic Differences in the Development of Cardio-Metabolic Diseases

    Article • Frontiers in Genetics, January 2017, Frontiers

    DSc Lidia Karabon

  22. Is the Genetic Background of Co-Stimulatory CD28/CTLA-4 Pathway the Risk Factor for Prostate Cancer?

    Article • Pathology & Oncology Research, January 2017, Springer Science + Business Media

    DSc Lidia Karabon

  23. Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia

    Article • Archivum Immunologiae et Therapiae Experimentalis, December 2016, Springer Science + Business Media

    DSc Lidia Karabon

  24. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease

    Article • Endocrine, September 2016, Springer Science + Business Media

    DSc Lidia Karabon

  25. Association of 3′ nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population

    Article • Urologic Oncology Seminars and Original Investigations, September 2016, Elsevier

    DSc Lidia Karabon

  26. Association of variants in BAFF (rs9514828 and rs1041569) and BAFF-R (rs61756766) genes with the risk of chronic lymphocytic leukemia

    Article • Tumor Biology, July 2016, Springer Science + Business Media

    DSc Lidia Karabon

  27. Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset

    Article • Journal of Neuroimmunology, November 2015, Elsevier

    DSc Lidia Karabon

  28. CTLA-4andCD28genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population - a prospective study

    Article • Tissue Antigens, September 2015, Wiley

    DSc Lidia Karabon

  29. Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL - a preliminary study on a Polish population

    Article • Tissue Antigens, August 2015, Wiley

    DSc Lidia Karabon

  30. CTLA4 and CD28 Gene Polymorphisms with Respect to Affective Symptom Domain in Schizophrenia

    Article • Neuropsychobiology, May 2015, Karger Publishers

    DSc Lidia Karabon

  31. A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation

    Article • Immunogenetics, May 2015, Springer Science + Business Media

    DSc Lidia Karabon

  32. Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation

    Article • Immunology Letters, May 2015, Elsevier

    DSc Lidia Karabon

  33. The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia

    Article • Leukemia & Lymphoma, March 2015, Taylor & Francis

    DSc Lidia Karabon

  34. Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia

    Article • March 2015, Taylor & Francis

    Dr Edyta Agnieszka Pawlak-Adamska, DSc Lidia Karabon

  35. Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk

    Article • Leukemia, November 2014, Springer Science + Business Media

    DSc Lidia Karabon

  36. Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation

    Article • European Archives of Psychiatry and Clinical Neuroscience, September 2014, Springer Science + Business Media

    DSc Lidia Karabon

  37. Gene Polymorphisms of Novel Immunotolerant Molecule BTLA: Distribution of Alleles, Genotypes and Haplotypes in Polish Caucasian Population

    Article • Archivum Immunologiae et Therapiae Experimentalis, September 2014, Springer Science + Business Media

    DSc Lidia Karabon

  38. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer

    Article • Human Immunology, June 2014, Elsevier

    DSc Lidia Karabon

  39. Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement

    Article • Rheumatology International, November 2013, Springer Science + Business Media

    DSc Lidia Karabon

  40. Genetic variants in transforming growth factor-β gene (TGFB1) affect susceptibility to schizophrenia

    Article • Molecular Biology Reports, September 2013, Springer Science + Business Media

    DSc Lidia Karabon

  41. The role of genetic variations of immune system regulatory molecules CD28 and CTLA-4 in schizophrenia

    Article • Psychiatry Research, July 2013, Elsevier

    DSc Lidia Karabon

  42. rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?

    Article • British Journal of Haematology, May 2013, Wiley

    DSc Lidia Karabon

  43. 16thIHIW: Population Global Distribution of Killer Immunoglobulin-like Receptor (KIR) and Ligands

    Article • International Journal of Immunogenetics, December 2012, Wiley

    DSc Lidia Karabon

  44. The Role of Polymorphisms in Co-Signalling Molecules’ Genes in Susceptibility to B-Cell Chronic Lymphocytic Leukaemia

    Article • February 2012, IntechOpen

    DSc Lidia Karabon

  45. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer

    Article • Human Immunology, October 2011, Elsevier

    DSc Lidia Karabon

  46. Variations in Suppressor Molecule CTLA-4 Gene Are Related to Susceptibility to Multiple Myeloma in a Polish Population

    Article • Pathology & Oncology Research, July 2011, Springer Science + Business Media

    DSc Lidia Karabon

  47. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease

    Article • Tissue Antigens, July 2011, Wiley

    DSc Lidia Karabon

  48. Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk

    Article • British Journal of Haematology, May 2011, Wiley

    DSc Lidia Karabon

  49. ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population

    Article • Folia Histochemica et Cytobiologica, April 2011, VM Media SP. zo.o VM Group SK

    DSc Lidia Karabon

  50. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population

    Article • Human Immunology, February 2010, Elsevier

    DSc Lidia Karabon

  51. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms

    Article • European Journal of Endocrinology, November 2009, Bioscientifica

    DSc Lidia Karabon

  52. TheCTLA-4gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease

    Article • Immunology, September 2009, Wiley

    DSc Lidia Karabon

  53. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population

    Article • Human Immunology, March 2008, Elsevier

    DSc Lidia Karabon

  54. Cytotoxic T-Lymphocyte Associated Antigen 4 Gene Polymorphisms and Autoimmune Thyroid Disease: A Meta-Analysis

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2007, Endocrine Society

    Professor Takuya Awata, Professor Dimitry A Chistiakov, DSc Lidia Karabon

  55. IL-6 Is Present in Sera of Bone Marrow-transplanted Patients in Aplastic Period and High Levels of IL-6 during Acute Graft-versus-Host Disease Are Associated with Severe Gut Symptomsa

    Article • Annals of the New York Academy of Sciences, December 2006, Wiley

    DSc Lidia Karabon

  56. Interleukin-6- and Interleukin-4-related Proteins (C-reactive Protein and IgE) Are Prognostic Factors of Asbestos-related Cancera

    Article • Annals of the New York Academy of Sciences, December 2006, Wiley

    DSc Lidia Karabon

  57. 2'-Deoxy-2'-fluoro- -D-arabinonucleic acid (2'F-ANA) modified oligonucleotides (ON) effect highly efficient, and persistent, gene silencing

    Article • Nucleic Acids Research, January 2006, Oxford University Press (OUP)

    DSc Lidia Karabon

  58. IL-6 and IL-10 Promoter Gene Polymorphisms of Patients and Donors of Allogeneic Sibling Hematopoietic Stem Cell Transplants Associate With the Risk of Acute Graft-Versus-Host Disease

    Article • Human Immunology, June 2005, Elsevier

    DSc Lidia Karabon

  59. IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma

    Article • Immunology Letters, January 2005, Elsevier

    DSc Lidia Karabon

  60. Lack of IFN-gamma 2/2 homozygous genotype independently of recipient age and intensity of conditioning regimen influences the risk of aGVHD manifestation after HLA-matched sibling haematopoietic stem cell transplantation

    Article • British Journal of Pharmacology, July 2004, Springer Science + Business Media

    DSc Lidia Karabon

  61. HLA typing for donor-recipient matching in unrelated donor hematopotetic stem cell transplantation

    Article • Transplantation Proceedings, March 2002, Elsevier

    DSc Lidia Karabon